Top news of the week: 19.01.2022.
Startups
With $3 billion, biotech veterans launch a global company aimed at disease ‘reversal’
With $3 billion, some of the biggest names in biotech are launching a global company aimed at disease "reversal."
'Shots on goal' to 'deterministic' drug development: Flagship CEO, Moderna Chair Noubar Afeyan pens first annual letter
Written in the middle of the largest pandemic wave to-date, Flagship Pioneering CEO and Moderna Chairman Noubar Afeyan, Ph.D., penned his first annual letter documenting the sea changes in ...
2022 NVCA Venture Capital Awards Ceremony
The NVCA Venture Capital Awards Ceremony celebrates the venture industry and honors those who have made significant contributions to foster innovation, advance technology, and drive new ...
The top 10 biopharma M&A deals in 2021
Biopharma merger and acquisition (M&A) activity was subdued in 2021 and would have approached a record low for recent years if not for a flurry of deals in the last quarter.
Novel Vaccines with Novel Targets Emerge at Biotech Showcase
Vaccine development is experiencing a resurgence in the wake of the COVID-19 pandemic, with companies developing a variety of approaches.
Felix Biotechnology to Collaborate with AnimalBiome on a Novel Solution for Pet Diarrhea
Felix Biotechnology to Collaborate with AnimalBiome on a Novel Solution for Pet Diarrhea - read this article along with other careers information, tips and advice on BioSpace
Flagship’s Afayan Outlines Biotech’s Top 4 Trends
Today, Noubar Afayan, founder of Flagship Pioneering, published the venture capital firm’s 2022 Annual Letter, and in it, outlined what he sees as the four top forces shaping the future of ...
A new biotech startup looks to sidestep a key problem with CAR-T cancer therapies
Cancer immunotherapy researcher Phil Greenberg is co-founding a new startup, called Affini-T, that aims to treat cancers by targeting the source of cancer cells.